Sphera Funds Management Ltd. Eledon Pharmaceuticals, Inc. Transaction History
Sphera Funds Management Ltd.
- $363 Million
- Q2 2025
A detailed history of Sphera Funds Management Ltd. transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,959,610 shares of ELDN stock, worth $5.21 Million. This represents 1.46% of its overall portfolio holdings.
Number of Shares
1,959,610
Previous 2,307,119
15.06%
Holding current value
$5.21 Million
Previous $7.82 Million
32.11%
% of portfolio
1.46%
Previous 2.06%
Shares
5 transactions
Others Institutions Holding ELDN
# of Institutions
86Shares Held
36.8MCall Options Held
48.5KPut Options Held
30.3K-
Bvf Inc San Francisco, CA6.29MShares$16.7 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$9.49 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$8.83 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.6MShares$6.92 Million1.08% of portfolio
-
Woodline Partners LP San Francisco, CA1.67MShares$4.45 Million0.03% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $36.6M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...